Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Genital Neoplasms, Female × 130-nm albumin-bound paclitaxel × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 39 Carcinoma, Non-Small-Cell Lung 31 Breast Neoplasms 29 Triple Negative Breast Neoplasms 15 Neoplasms 13 Neoplasm Metastasis 10 Carcinoma 9 Adenocarcinoma 8 Lung Neoplasms 7 Colorectal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Pancreatic Diseases 5 Head and Neck Neoplasms 5 Carcinoma, Squamous Cell 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Neoplasms by Site 4 Digestive System Neoplasms 4 Digestive System Diseases 4 Pancreatic Adenocarcinoma 3 Neoplasms by Histologic Type 3 Melanoma 3 Endocrine System Diseases 3 Endocrine Gland Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Pancreatic Ductal 3 Carcinoma, Ovarian Epithelial 3 Uveal Melanoma 2 Urinary Bladder Neoplasms 2 Tongue Neoplasms 2 Stomach Neoplasms 2

Interventions

pembrolizumab 2 Pemetrexed 1 Palliative Care 1 Paclitaxel 1 Gemcitabine 1 Educational Status 1 Carboplatin 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡